DANIELMEDINADANIEL MEDINA0.000000000000000.000000000000002439MEDINA, DANIELProfessor Emeritusprns:coAuthorOfcoauthor ofprns:endDateend dateFaculty Rankprns:fullNamefull nameprns:grantAwardedBygrant awarded byprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:principalInvestigatorNameprincipal investigator nameprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:startDatestart dateprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressAgreementvivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionGrantvivo:hasResearchArearesearch areasvivo:hasResearcherRoleresearch activitiesvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleResearcher Rolevivo:researcherRoleOfresearcher role ofRolevivo:roleContributesTocontributes tovivo:sponsorAwardIdsponsor award idrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAuthorship 862641Authorship 945811Authorship 941065Authorship 10034514Authorship 161903225774287Suo J, Medina D, Herrera S, Zheng ZY, Jin L, Chamness GC, Contreras A, Gutierrez C, Hilsenbeck S, Umar A, Foekens JA, Hanash S, Schiff R, Zhang XH, Chang ECCell & bioscienceInt6 reduction activates stromal fibroblasts to enhance transforming activity in breast epithelial cells. Cell Biosci. 2015; 5:10.Cell Biosci2015-03-08T00:00:002015Int6 reduction activates stromal fibroblasts to enhance transforming activity in breast epithelial cells.Authorship 259971Authorship 278177Authorship 383185Authorship 4049613Clinical Cancer PreventionGeneticsMolecular & Cellular OncologyMD AndersonMIEN-CHIEHUNGMIEN-CHIE HUNG8427HUNG, MIEN-CHIEProfessorPOWEL HBROWNPOWEL H BROWN9636BROWN, POWEL HProfessorGUILLERMINALOZANOGUILLERMINA LOZANO8500LOZANO, GUILLERMINAProfessorAuthorship 544518Authorship 657451Authorship 952341Authorship 3047861326166574Zheng ZY, Tian L, Bu W, Fan C, Gao X, Wang H, Liao YH, Li Y, Lewis MT, Edwards D, Zwaka TP, Hilsenbeck SG, Medina D, Perou CM, Creighton CJ, Zhang XH, Chang ECCell reportsWild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 Activation. Cell Rep. 2015 Jul 21; 12(3):511-24.Cell Rep2015-07-09T00:00:002015Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 Activation.12083633Sivaraman L, Gay J, Hilsenbeck SG, Shine HD, Conneely OM, Medina D, O'Malley BWBreast cancer research and treatmentEffect of selective ablation of proliferating mammary epithelial cells on MNU induced rat mammary tumorigenesis. Breast Cancer Res Treat. 2002 May; 73(1):75-83.Breast Cancer Res Treat2002-05-01T00:00:002002Effect of selective ablation of proliferating mammary epithelial cells on MNU induced rat mammary tumorigenesis.12160088Sivaraman L, Medina DJournal of mammary gland biology and neoplasiaHormone-induced protection against breast cancer. J Mammary Gland Biol Neoplasia. 2002 Jan; 7(1):77-92.J Mammary Gland Biol Neoplasia2002-01-01T00:00:002002Hormone-induced protection against breast cancer.14734495Medina DClinical cancer research : an official journal of the American Association for Cancer ResearchBreast cancer: the protective effect of pregnancy. Clin Cancer Res. 2004 Jan 01; 10(1 Pt 2):380S-4S.Clin Cancer Res2004-01-01T00:00:002004Breast cancer: the protective effect of pregnancy.15585572Medina D, Kittrell FJournal of cell scienceStroma is not a major target in DMBA-mediated tumorigenesis of mouse mammary preneoplasia. J Cell Sci. 2005 Jan 01; 118(Pt 1):123-7.J Cell Sci2004-12-07T00:00:002004Stroma is not a major target in DMBA-mediated tumorigenesis of mouse mammary preneoplasia.12124350Goepfert TM, Adigun YE, Zhong L, Gay J, Medina D, Brinkley WRCancer researchCentrosome amplification and overexpression of aurora A are early events in rat mammary carcinogenesis. Cancer Res. 2002 Jul 15; 62(14):4115-22.Cancer Res2002-07-15T00:00:002002Centrosome amplification and overexpression of aurora A are early events in rat mammary carcinogenesis.74Professor10Assistant Professor14Associate Professor2Adjunct Assistant Professor3Adjunct Associate Professor78Professor Emeritus6Adjunct Professor47Distinguished Service Professor16140972Kuang SQ, Liao L, Wang S, Medina D, O'Malley BW, Xu JCancer researchMice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis. Cancer Res. 2005 Sep 01; 65(17):7993-8002.Cancer Res2005-09-01T00:00:002005Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis.17131329Goepfert TM, Moreno-Smith M, Edwards DG, Pathak S, Medina D, Brinkley WRInternational journal of cancerLoss of chromosomal integrity drives rat mammary tumorigenesis. Int J Cancer. 2007 Mar 01; 120(5):985-94.Int J Cancer2007-03-01T00:00:002007Loss of chromosomal integrity drives rat mammary tumorigenesis.12615724Medina D, Kittrell FS, Shepard A, Contreras A, Rosen JM, Lydon JCancer researchHormone dependence in premalignant mammary progression. Cancer Res. 2003 Mar 01; 63(5):1067-72.Cancer Res2003-03-01T00:00:002003Hormone dependence in premalignant mammary progression.17965942Li Z, Schem C, Shi YH, Medina D, Zhang MClinical & experimental metastasisIncreased COX2 expression enhances tumor-induced osteoclastic lesions in breast cancer bone metastasis. Clin Exp Metastasis. 2008; 25(4):389-400.Clin Exp Metastasis2007-10-27T00:00:002007Increased COX2 expression enhances tumor-induced osteoclastic lesions in breast cancer bone metastasis.18089834Loehberg CR, Thompson T, Kastan MB, Maclean KH, Edwards DG, Kittrell FS, Medina D, Conneely OM, O'Malley BWCancer researchAtaxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis. Cancer Res. 2007 Dec 15; 67(24):12026-33.Cancer Res2007-12-15T00:00:002007Ataxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis.18559513Zhang M, Behbod F, Atkinson RL, Landis MD, Kittrell F, Edwards D, Medina D, Tsimelzon A, Hilsenbeck S, Green JE, Michalowska AM, Rosen JMCancer researchIdentification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res. 2008 Jun 15; 68(12):4674-82.Cancer Res2008-06-15T00:00:002008Identification of tumor-initiating cells in a p53-null mouse model of breast cancer.14559792Medina D, Kittrell FSCancer researchp53 function is required for hormone-mediated protection of mouse mammary tumorigenesis. Cancer Res. 2003 Oct 01; 63(19):6140-3.Cancer Res2003-10-01T00:00:002003p53 function is required for hormone-mediated protection of mouse mammary tumorigenesis.15051868Medina DProceedings of the National Academy of Sciences of the United States of AmericaStromal fibroblasts influence human mammary epithelial cell morphogenesis. Proc Natl Acad Sci U S A. 2004 Apr 06; 101(14):4723-4.Proc Natl Acad Sci U S A2004-03-29T00:00:002004Stromal fibroblasts influence human mammary epithelial cell morphogenesis.15105443Yi Y, Shepard A, Kittrell F, Mulac-Jericevic B, Medina D, Said TKMolecular biology of the cellp19ARF determines the balance between normal cell proliferation rate and apoptosis during mammary gland development. Mol Biol Cell. 2004 May; 15(5):2302-11.Mol Biol Cell2004-05-01T00:00:002004p19ARF determines the balance between normal cell proliferation rate and apoptosis during mammary gland development.20145191Dearth RK, Delgado DA, Hiney JK, Pathiraja T, Oesterreich S, Medina D, Dees WL, Lee AVCancer prevention research (Philadelphia, Pa.)Parity-induced decrease in systemic growth hormone alters mammary gland signaling: a potential role in pregnancy protection from breast cancer. Cancer Prev Res (Phila). 2010 Mar; 3(3):312-21.Cancer Prev Res (Phila)2010-02-09T00:00:002010Parity-induced decrease in systemic growth hormone alters mammary gland signaling: a potential role in pregnancy protection from breast cancer.20630995Medina DCold Spring Harbor perspectives in biologyOf mice and women: A short history of mouse mammary cancer research with an emphasis on the paradigms inspired by the transplantation method. Cold Spring Harb Perspect Biol. 2010 Oct; 2(10):a004523.Cold Spring Harb Perspect Biol2010-07-14T00:00:002010Of mice and women: A short history of mouse mammary cancer research with an emphasis on the paradigms inspired by the transplantation method.15535853Allred DC, Brown P, Medina DBreast cancer research : BCRThe origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer. Breast Cancer Res. 2004; 6(6):240-5.Breast Cancer Res2004-09-22T00:00:002004The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer.16417654Lee S, Mohsin SK, Mao S, Hilsenbeck SG, Medina D, Allred DCBreast cancer research : BCRHormones, receptors, and growth in hyperplastic enlarged lobular units: early potential precursors of breast cancer. Breast Cancer Res. 2006; 8(1):R6.Breast Cancer Res2005-12-16T00:00:002005Hormones, receptors, and growth in hyperplastic enlarged lobular units: early potential precursors of breast cancer.21466693Kittrell FS, Carletti MZ, Kerbawy S, Heestand J, Xian W, Zhang M, Lamarca HL, Sonnenberg A, Rosen JM, Medina D, Behbod FBreast cancer research : BCRProspective isolation and characterization of committed and multipotent progenitors from immortalized mouse mammary epithelial cells with morphogenic potential. Breast Cancer Res. 2011 Apr 05; 13(2):R41.Breast Cancer Res2011-04-05T00:00:002011Prospective isolation and characterization of committed and multipotent progenitors from immortalized mouse mammary epithelial cells with morphogenic potential.15833886Medina D, Kittrell FS, Hill J, Shepard A, Thordarson G, Brown PCancer researchTamoxifen inhibition of estrogen receptor-alpha-negative mouse mammary tumorigenesis. Cancer Res. 2005 Apr 15; 65(8):3493-6.Cancer Res2005-04-15T00:00:002005Tamoxifen inhibition of estrogen receptor-alpha-negative mouse mammary tumorigenesis.17996864Gatza CE, Dumble M, Kittrell F, Edwards DG, Dearth RK, Lee AV, Xu J, Medina D, Donehower LADevelopmental biologyAltered mammary gland development in the p53+/m mouse, a model of accelerated aging. Dev Biol. 2008 Jan 01; 313(1):130-41.Dev Biol2007-10-12T00:00:002007Altered mammary gland development in the p53+/m mouse, a model of accelerated aging.18057544Medina DBreast diseaseChemical carcinogenesis of rat and mouse mammary glands. Breast Dis. 2007; 28:63-8.Breast Dis2007-01-01T00:00:002007Chemical carcinogenesis of rat and mouse mammary glands.18663563Medina DJournal of mammary gland biology and neoplasiaPremalignant and malignant mammary lesions induced by MMTV and chemical carcinogens. J Mammary Gland Biol Neoplasia. 2008 Sep; 13(3):271-7.J Mammary Gland Biol Neoplasia2008-07-29T00:00:002008Premalignant and malignant mammary lesions induced by MMTV and chemical carcinogens.18728194Zhang N, Ge G, Meyer R, Sethi S, Basu D, Pradhan S, Zhao YJ, Li XN, Cai WW, El-Naggar AK, Baladandayuthapani V, Kittrell FS, Rao PH, Medina D, Pati DProceedings of the National Academy of Sciences of the United States of AmericaOverexpression of Separase induces aneuploidy and mammary tumorigenesis. Proc Natl Acad Sci U S A. 2008 Sep 02; 105(35):13033-8.Proc Natl Acad Sci U S A2008-08-26T00:00:002008Overexpression of Separase induces aneuploidy and mammary tumorigenesis.19174577Medina D, Kittrell F, Hill J, Zhang Y, Hilsenbeck SG, Bissonette R, Brown PHCancer prevention research (Philadelphia, Pa.)Prevention of tumorigenesis in p53-null mammary epithelium by rexinoid bexarotene, tyrosine kinase inhibitor gefitinib, and celecoxib. Cancer Prev Res (Phila). 2009 Feb; 2(2):168-74.Cancer Prev Res (Phila)2009-01-27T00:00:002009Prevention of tumorigenesis in p53-null mammary epithelium by rexinoid bexarotene, tyrosine kinase inhibitor gefitinib, and celecoxib.19267898Kaipparettu BA, Dobrzycka KM, Britton O, Lee AV, Herron AJ, Li Y, Lewis MT, Medina D, Oesterreich SMolecular cancerScaffold Attachment Factor B1 (SAFB1) heterozygosity does not influence Wnt-1 or DMBA-induced tumorigenesis. Mol Cancer. 2009 Mar 06; 8:15.Mol Cancer2009-03-06T00:00:002009Scaffold Attachment Factor B1 (SAFB1) heterozygosity does not influence Wnt-1 or DMBA-induced tumorigenesis.Authorship 65244913Authorship 652498527307599Bansal N, Bartucci M, Yusuff S, Davis S, Flaherty K, Huselid E, Patrizii M, Jones D, Cao L, Sydorenko N, Moon YC, Zhong H, Medina DJ, Kerrigan J, Stein MN, Kim IY, Davis TW, DiPaola RS, Bertino JR, Sabaawy HEClinical cancer research : an official journal of the American Association for Cancer ResearchBMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate Cancer. Clin Cancer Res. 2016 Dec 15; 22(24):6176-6191.Clin Cancer Res2016-06-15T00:00:002016BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate Cancer.27446983Kittrell F, Valdez K, Elsarraj H, Hong Y, Medina D, Behbod FBio-protocolMouse Mammary Intraductal (MIND) Method for Transplantation of Patient Derived Primary DCIS Cells and Cell Lines. Bio Protoc. 2016 Mar 05; 6(5).Bio Protoc2016-03-05T00:00:002016Mouse Mammary Intraductal (MIND) Method for Transplantation of Patient Derived Primary DCIS Cells and Cell Lines.22609880Budak-Alpdogan T, Jeganathan G, Lee KC, Mrowiec ZR, Medina DJ, Todd D, Moore D, Bertino JR, Strair RBone marrow transplantationIrradiated allogeneic cells enhance umbilical cord blood stem cell engraftment in immunodeficient mice. Bone Marrow Transplant. 2012 Dec; 47(12):1569-76.Bone Marrow Transplant2012-05-21T00:00:002012Irradiated allogeneic cells enhance umbilical cord blood stem cell engraftment in immunodeficient mice.22688217Medina D, Edwards DG, Kittrell F, Lee S, Allred DCJournal of mammary gland biology and neoplasiaIntra-mammary ductal transplantation: a tool to study premalignant progression. J Mammary Gland Biol Neoplasia. 2012 Jun; 17(2):131-3.J Mammary Gland Biol Neoplasia2012-06-12T00:00:002012Intra-mammary ductal transplantation: a tool to study premalignant progression.22581302Lewis MT, Landua JD, Adams HC, Medina DJournal of mammary gland biology and neoplasiaA mystery wrapped in an enigma: Matrigel enhancement of mammary cell growth and morphogenesis. J Mammary Gland Biol Neoplasia. 2012 Jun; 17(2):99-101.J Mammary Gland Biol Neoplasia2012-05-13T00:00:002012A mystery wrapped in an enigma: Matrigel enhancement of mammary cell growth and morphogenesis.23408103Machado HL, Kittrell FS, Edwards D, White AN, Atkinson RL, Rosen JM, Medina D, Lewis MTStem cells translational medicineSeparation by cell size enriches for mammary stem cell repopulation activity. Stem Cells Transl Med. 2013 Mar; 2(3):199-203.Stem Cells Transl Med2013-02-13T00:00:002013Separation by cell size enriches for mammary stem cell repopulation activity.11921187Medina D, Ullrich R, Meyn R, Wiseman R, Donehower LEnvironmental and molecular mutagenesisEnvironmental carcinogens and p53 tumor-suppressor gene interactions in a transgenic mouse model for mammary carcinogenesis. Environ Mol Mutagen. 2002; 39(2-3):178-83.Environ Mol Mutagen2002-01-01T00:00:002002Environmental carcinogens and p53 tumor-suppressor gene interactions in a transgenic mouse model for mammary carcinogenesis.15082920Said TK, Medina DJournal of mammary gland biology and neoplasiaCell cycle genes in a mouse mammary hyperplasia model. J Mammary Gland Biol Neoplasia. 2004 Jan; 9(1):81-93.J Mammary Gland Biol Neoplasia2004-01-01T00:00:002004Cell cycle genes in a mouse mammary hyperplasia model.15313898Pati D, Haddad BR, Haegele A, Thompson H, Kittrell FS, Shepard A, Montagna C, Zhang N, Ge G, Otta SK, McCarthy M, Ullrich RL, Medina DCancer researchHormone-induced chromosomal instability in p53-null mammary epithelium. Cancer Res. 2004 Aug 15; 64(16):5608-16.Cancer Res2004-08-15T00:00:002004Hormone-induced chromosomal instability in p53-null mammary epithelium.16172188Medina DEndocrine-related cancerMammary developmental fate and breast cancer risk. Endocr Relat Cancer. 2005 Sep; 12(3):483-95.Endocr Relat Cancer2005-09-01T00:00:002005Mammary developmental fate and breast cancer risk.21633010Herschkowitz JI, Zhao W, Zhang M, Usary J, Murrow G, Edwards D, Knezevic J, Greene SB, Darr D, Troester MA, Hilsenbeck SG, Medina D, Perou CM, Rosen JMProceedings of the National Academy of Sciences of the United States of AmericaComparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells. Proc Natl Acad Sci U S A. 2012 Feb 21; 109(8):2778-83.Proc Natl Acad Sci U S A2011-06-01T00:00:002011Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells.22926341Mazumdar A, Medina D, Kittrell FS, Zhang Y, Hill JL, Edwards DE, Bissonnette RP, Brown PHCancer prevention research (Philadelphia, Pa.)The combination of tamoxifen and the rexinoid LG100268 prevents ER-positive and ER-negative mammary tumors in p53-null mammary gland mice. Cancer Prev Res (Phila). 2012 Oct; 5(10):1195-202.Cancer Prev Res (Phila)2012-08-27T00:00:002012The combination of tamoxifen and the rexinoid LG100268 prevents ER-positive and ER-negative mammary tumors in p53-null mammary gland mice.true1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Professor EmeritusProfessor EmeritusAuthorship 1055301D008321Anatomy1495330.740409Mammary Glands, AnimalD008325Disorders2044930.762474Mammary Neoplasms, ExperimentalD015674Disorders1302210.835187Mammary Neoplasms, AnimalAuthorship 1031684D011374Chemicals & Drugs1425140.802975Progesteronetrue1Assistant ProfessorAssistant ProfessorAuthorship 1088221Authorship 1078491D002273Chemicals & Drugs1773840.878867CarcinogensAuthorship 934969429590203Palaniappan M, Edwards D, Creighton CJ, Medina D, Conneely OMPloS oneReprogramming of the estrogen responsive transcriptome contributes to tamoxifen-dependent protection against tumorigenesis in the p53 null mammary epithelial cells. PLoS One. 2018; 13(3):e0194913.PLoS One2018-03-28T00:00:002018Reprogramming of the estrogen responsive transcriptome contributes to tamoxifen-dependent protection against tumorigenesis in the p53 null mammary epithelial cells.1999-11-30NIHMEDINA, DANIEL NONE1988-04-01EARLY EVENTS IN MULTIPLE-STAGE MAMMARY TUMORIGENESISR01CA0471122005-12-31NIHMEDINA, DANIEL NONE2000-01-01P53 AND MOUSE MAMMARY TUMORIGENESISR01CA0843202008-04-30NIHMEDINA, DANIEL NONE1995-08-01Mechanisms of the Hormonal Prevention of Breast CancerP01CA0642551997-04-30NIHMEDINA, DANIEL NONE1994-05-01IMMORTALIZATION AND MAMMORY TUMORIGENESISR01CA0631372010-03-31NIHROSEN, JEFFREY1999-09-30Mouse Models of Human Breast CancerU01CA0842432005-04-30NIHMEDINA, DANIEL NONE1977-09-30BIOLOGY OF MOUSE MAMMARY PRENEOPLASIASR01CA0119441987-12-31NIHMEDINA, DANIEL NONE1985-01-01CELL LINEAGES IN NORMAL AND PRENEOPLASTIC MAMMARY GROWTHR01CA0390171992-07-31NIHMEDINA, DANIEL NONE1991-08-01GORDON RESEARCH CONFERENCE--MAMMARY GLAND BIOLOGYR13CA055154Principal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorCo-Principal InvestigatorPrincipal InvestigatorPrincipal InvestigatorDepartment of MedicineDepartment of PediatricsDepartment of Molecular & Cellular BiologyMedicine-Hematology & OncologyMolecular & Cellular BiologyPediatrics-OncologyBaylor College of MedicineANILPANIGRAHIANIL PANIGRAHI0.000000000000000.000000000000001231PANIGRAHI, ANILAssistant ProfessorDEBANANDAPATIDEBANANDA PATI0.000000000000000.000000000000003475PATI, DEBANANDAProfessorMICHAELLEWISMICHAEL LEWIS0.000000000000000.00000000000000353LEWIS, MICHAELProfessorJEFFREYROSENJEFFREY ROSEN0.000000000000000.000000000000002492ROSEN, JEFFREYDistinguished Service ProfessorYILIYI LI0.000000000000000.00000000000000520LI, YIProfessorFRANCESCODEMAYOFRANCESCO DEMAYO0.000000000000000.000000000000003030DEMAYO, FRANCESCOAdjunct ProfessorPREETHIGUNARATNEPREETHI GUNARATNE0.000000000000000.000000000000003337GUNARATNE, PREETHIAdjunct Associate ProfessorXIAOTAOLIXIAOTAO LI0.000000000000000.00000000000000376LI, XIAOTAOAdjunct Assistant ProfessorSUSANHILSENBECKSUSAN HILSENBECK0.000000000000000.000000000000003634HILSENBECK, SUSANProfessor2.739250.00439519267research areas0.6832880.013694329coauthor of50.43276.9795460similar to1147selected publicationsJOHNLYDONJOHN LYDON0.000000000000000.000000000000003271LYDON, JOHNAssociate ProfessorAuthorship 1272561423922822Mehta MS, Dolfi SC, Bronfenbrener R, Bilal E, Chen C, Moore D, Lin Y, Rahim H, Aisner S, Kersellius RD, Teh J, Chen S, Toppmeyer DL, Medina DJ, Ganesan S, Vazquez A, Hirshfield KMPloS oneMetabotropic glutamate receptor 1 expression and its polymorphic variants associate with breast cancer phenotypes. PLoS One. 2013; 8(7):e69851.PLoS One2013-07-26T00:00:002013Metabotropic glutamate receptor 1 expression and its polymorphic variants associate with breast cancer phenotypes.true1ProfessorProfessorAuthorship 1120991true1Distinguished Service ProfessorDistinguished Service ProfessorAuthorship 1091092Authorship 114726true1Adjunct Assistant ProfessorAdjunct Assistant ProfessorAuthorship 113756Authorship 1002227133025158Medina DJournal of mammary gland biology and neoplasiaIn Memoriam - Gilbert Howlett Smith 1938-2020. J Mammary Gland Biol Neoplasia. 2020 09; 25(3):177.J Mammary Gland Biol Neoplasia2020-10-06T00:00:002020In Memoriam - Gilbert Howlett Smith 1938-2020.true1Adjunct ProfessorAdjunct ProfessorAuthorship 1138211true1ProfessorProfessorAuthorship 133427true1Adjunct Associate ProfessorAdjunct Associate ProfessorAuthorship 1373751424197133Rehman SK, Li SH, Wyszomierski SL, Wang Q, Li P, Sahin O, Xiao Y, Zhang S, Xiong Y, Yang J, Wang H, Guo H, Zhang JD, Medina D, Muller WJ, Yu DCancer research14-3-3? orchestrates mammary tumor onset and progression via miR-221-mediated cell proliferation. Cancer Res. 2014 Jan 01; 74(1):363-373.Cancer Res2013-11-06T00:00:00201314-3-3? orchestrates mammary tumor onset and progression via miR-221-mediated cell proliferation.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessorAuthorship 179974Authorship 28036324276237Mukherjee M, Ge G, Zhang N, Edwards DG, Sumazin P, Sharan SK, Rao PH, Medina D, Pati DOncogeneMMTV-Espl1 transgenic mice develop aneuploid, estrogen receptor alpha (ERa)-positive mammary adenocarcinomas. Oncogene. 2014 Nov 27; 33(48):5511-5522.Oncogene2013-11-25T00:00:002013MMTV-Espl1 transgenic mice develop aneuploid, estrogen receptor alpha (ERa)-positive mammary adenocarcinomas.Authorship 3199010Authorship 326431Authorship 262451Authorship 142684124722054Medina DJ, Abass-Shereef J, Walton K, Goodell L, Aviv H, Strair RK, Budak-Alpdogan TPloS oneCobblestone-area forming cells derived from patients with mantle cell lymphoma are enriched for CD133+ tumor-initiating cells. PLoS One. 2014; 9(4):e91042.PLoS One2014-04-10T00:00:002014Cobblestone-area forming cells derived from patients with mantle cell lymphoma are enriched for CD133+ tumor-initiating cells.Authorship 352162Authorship 51745Authorship 533372Authorship 146272224747123Dolfi SC, J?ger AV, Medina DJ, Haffty BG, Yang JM, Hirshfield KMCancer lettersFulvestrant treatment alters MDM2 protein turnover and sensitivity of human breast carcinoma cells to chemotherapeutic drugs. Cancer Lett. 2014 Aug 01; 350(1-2):52-60.Cancer Lett2014-04-18T00:00:002014Fulvestrant treatment alters MDM2 protein turnover and sensitivity of human breast carcinoma cells to chemotherapeutic drugs.Authorship 697085Authorship 711901Authorship 5461712Authorship 545517Authorship 85464Authorship 1535588Authorship 718268Authorship 767955